GSE165334 2 V 0 DABRAFENIB HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE165334 2 V 0 DABRAFENIB HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE165334 2 V 0 DABRAFENIB HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE165334 2 V 0 DABRAFENIB HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE165334 2 V 0 DABRAFENIB HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

ribosomal protein SA 2

Gene

POU class 3 homeobox 3

Gene

synaptotagmin 15B

Gene

TP53 target 3 family member F

Gene

olfactory receptor family 14 subfamily J member 1

Gene

family with sequence similarity 204 member A

Gene

CCR4-NOT transcription complex subunit 6 like

Gene

twist family bHLH transcription factor 2

Gene

R-spondin 3

  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    ribosomal protein SA 2


  • Gene

    POU class 3 homeobox 3


  • Gene

    synaptotagmin 15B


  • Gene

    TP53 target 3 family member F


  • Gene

    olfactory receptor family 14 subfamily J member 1


  • Gene

    family with sequence similarity 204 member A


  • Gene

    CCR4-NOT transcription complex subunit 6 like


  • Gene

    twist family bHLH transcription factor 2


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.